A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy.

@article{Fontenot2005APR,
  title={A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy.},
  author={M Todd Fontenot and David F. Lewis and J Brian Frederick and Yuping Wang and Emily A. DeFranco and Lynn J. Groome and Arthur T. Evans},
  journal={American journal of obstetrics and gynecology},
  year={2005},
  volume={192 6},
  pages={1788-93; discussion 1793-4}
}
OBJECTIVE The purpose of this study was to assess the use of the onset of diuresis in the determination of the duration of postpartum magnesium sulfate therapy among patients with severe preeclampsia. STUDY DESIGN A prospective randomized trial of postpartum therapy with magnesium sulfate was conducted. The control group received 24 hours of therapy, and the study group received therapy until the onset of diuresis (urine output >100 mL/hr for 2 consecutive hours). The Student t test, chi 2… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…